Da Volterra and BioAster Sign Partnership Agreement

Da Volterra and BioAster Sign Partnership Agreement


Back to news page

Da Volterra and BioAster Sign Partnership Agreement

BIOASTER and DA VOLTERRA announced the signature of a full partnership agreement to develop a new product concept in the field of anti-infection, this follows on from an initial memorandum of understanding signed in 2013.

This is a unique opportunity to push forward an exciting innovative product designed to combat antibiotic resistance by pooling the long expertise of Da Volterra in the field and the recently set-up teams of BIOASTER in Paris and Lyon. The project, entitled DACCAR, (Destroy Antibiotics in Colon to Combat Antibiotic Resistance), aims to develop an innovative product limiting the emergence of multi-resistant bacteria in patients treated with antibiotics, thus protecting the intestinal microbial flora from antibiotics side effects.

Using a DACCAR product could result in minimizing nosocomial infections burden, maintaining the effectiveness of antibiotics (noteworthy carbapenems) reducing the spread of antibiotic resistance.

More infos on BIOASTER available at http://bioaster.org/.